The upcoming edition spans Halls C, E, and The Platz, hosting roughly 420 companies from more than 70 countries. This convergence of international and domestic players highlights Korea’s advanced CDMO infrastructure and its rapidly evolving nutraceutical market. Major organizations, including the Ministry of Food and Drug Safety and the Korea Drug Research Association, are backing the event to foster cross-border collaborations and strategic partnerships across the Asian market.
In section Releases
CPHI/ Hi Korea 2026 Expands Footprint to Host Growing Pharma Sector
With exhibition space growing 14% year-on-year, Informa Markets Korea has opened pre-registration for CPHI/ Hi Korea 2026. The event, scheduled for August 25–27 at Seoul’s COEX, expects to draw over 12,000 professionals as the nation solidifies its position as a global hub for biopharma and health innovation.
To address surging industry interest, the conference program has grown to six distinct tracks. These sessions will delve into critical developments such as ADC, TPD, and RPT technologies, alongside clinical trial updates and the latest GLP-1 research. Specialized forums and a Startup Challenge are designed to support commercialization, providing a springboard for market entry into the United States, Japan, China, Thailand, and Malaysia. With Hall E nearing capacity, organizers are advising prospective exhibitors to finalize applications immediately.
Comments (0)
No comments yet. Be the first!